-
Novelos Therapeutics Inc. (OTCQX:NVLT), Newton, Mass. Business: Cancer, Infectious Date announced: 5/14/12 Type: Private placement of units To be raised: Up to $23 million Units: 5 million Price prior: $0.86 Placement …
Published on 5/21/2012
-
Arena Pharmaceuticals Inc. (NASDAQ:ARNA), San Diego, Calif. Business: Endocrine/Metabolic, Neurology, Cardiovascular Date completed: 5/16/12 Type: Follow-on Raised: $60.5 million Shares: 11 million Price: $5.50 Shares …
Published on 5/21/2012
-
Cellceutix Corp. (OTCQB: CTIX), Beverly, Mass. Business: Cancer, Autoimmune, Inflammation Date completed: 5/14/12 Type: Private placement of convertible preferred stock Raised: $100,000 Shares: 10,000 Price: $1,000 …
Published on 5/21/2012
-
Cytos Biotechnology AG (SIX: CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Cardiovascular Date completed: 5/15/12 Type: Private placement Raised: CHF23.7 million ($25.5 million) Shares: 12.7 million …
Published on 5/21/2012
-
Cytos Biotechnology AG (SIX: CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Cardiovascular Date completed: 5/15/12 Type: Private placement of senior convertible notes Raised: CHF6.6 million ($7.1 …
Published on 5/21/2012
-
Cytos Biotechnology AG (SIX: CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Cardiovascular Date completed: 5/10/12 Type: Rights offering Raised: CHF3.2 million ($3.4 million) Shares: 1.7 million Price:…
Published on 5/21/2012
-
Gamida Cell Ltd., Jerusalem, Israel Business: Hematology, Cardiovascular, Neurology Date completed: 5/15/12 Type: Venture financing Raised: $10 million Investors: Clal Biotechnology Industries; Elbit Imaging; Israel …
Published on 5/21/2012
-
Intercell AG (VSE:ICLL; OTCQX: INRLY), Vienna, Austria Business: Infectious Date completed: 5/14/12 Type: Debt financing Raised: 20 million ($25.8 million) Investor: BB Biotech Note: The six-year secured loan bears …
Published on 5/21/2012
-
Intercell AG (VSE:ICLL; OTCQX: INRLY), Vienna, Austria Business: Infectious Date completed: 5/14/12 Type: Private placement Raised: 15.2 million ($19.5 million) Shares: 6.6 million Price: 2.30 Shares after offering: 55.…
Published on 5/21/2012
-
Marshall Edwards Inc. (NASDAQ: MSHL), San Diego, Calif. Business: Cancer Date completed: 5/14/12 Type: Rights offering of units Raised: $5.2 million Units: 11.7 million Price: $0.45 (unit) Shares after offering: 20.5 …
Published on 5/21/2012
-
Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Business: Dermatology Date completed: 5/11/12 Type: Private placement of senior convertible notes Raised: $450 million Underwriters: Deutsche Bank; JPMorgan …
Published on 5/21/2012
-
Quest PharmaTech Inc. (TSX-V:QPT), Edmonton, Alberta Business: Dermatology, Cancer, Diagnostic Date completed: 5/14/12 Type: Private placement Raised: C$500,000 ($498,500) Shares: 5 million Price: C$0.10 Shares after …
Published on 5/21/2012
-
Regenerative Sciences Inc., Broomfield, Colo. Business: Gastrointestinal Date completed: 5/14/12 Type: Venture financing Raised: $2 million Investor: Private investor
Published on 5/21/2012
-
Regentis Biomaterials Ltd., Or-Akiva, Israel Business: Musculoskeletal Date completed: 5/14/12 Type: Venture financing Raised: $10 million Investors: Royal DSM N.V.; Crossroad Fund; Medica Venture Partners; SCP Vitalife…
Published on 5/21/2012
-
SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Date completed: 5/17/12 Type: Private placement of units Raised: C$4.9 million ($4.9 million) Units: 2.8 million Price: C$1.75 (unit) Shares after …
Published on 5/21/2012
-
Stellar Pharmaceuticals Inc. (OTCQB: SLXCF), London, Ontario Business: Autoimmune, Genitourinary, Diagnostic Date completed: 5/14/12 Type: Debt financing Raised: $3.5 million Placement agent: Bloom Burton Shares …
Published on 5/21/2012
-
Aeterna Zentaris Inc. (TSX: AEZ; NASDAQ:AEZS), Quebec City, Quebec Business: Endocrine/Metabolic, Cancer Date announced: 5/16/12 Aeterna Zentaris received notice from NASDAQ indicating that the company is not in …
Published on 5/21/2012
-
Axonia Medical Inc., Kalamazoo, Mich. Business: Transplant Date announced: 5/10/12 Axonia Medical raised $1 million in the second close of a seed financing, bringing the total raised to $2 million. The financing was led…
Published on 5/21/2012
-
CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer, Neurology Date announced: 5/15/12 CytRx implemented a 1-for-7 reverse stock split. Following the split, the company has about 21.3 million shares …
Published on 5/21/2012
-
D. Medical Industries Ltd. (NASDAQ:DMED; Tel Aviv: DMED), Tirat Carmel, Israel Business: Drug delivery, Endocrine/Metabolic Date announced: 5/10/12 D. Medical received notice from NASDAQ indicating that the company is …
Published on 5/21/2012
-
Helix BioMedix Inc. (OTCQB: HXBM), Bothell, Wash. Business: Dermatology, Pulmonary, Infectious Date announced: 5/11/12 Helix BioMedix disclosed in its 1Q12 earnings that it secured a $2 million line of credit with …
Published on 5/21/2012
-
Kleiner Perkins Caufield & Byers, Menlo Park, Calif. Business: Finance Date announced: 5/17/12 Kleiner Perkins Caufield & Byers closed its $525 million KPCB XV fund. The fund will invest in early stage digital consumer …
Published on 5/21/2012
-
MannKind Corp. (NASDAQ: MNKD), Valencia, Calif. Business: Endocrine/Metabolic, Cancer Date announced: 5/9/12 MannKind extended the maturity date to July 1, 2013, from March 31, 2013, for its $350 million loan with …
Published on 5/21/2012
-
Prolor Biotech Inc. (NYSE-A:PBTH; Tel Aviv:PBTH), Ness Ziona, Israel Business: Endocrine/Metabolic, Hematology Date announced: 5/16/12 Prolor raised $4.9 million through the sale of 975,000 shares at $5 to cover the …
Published on 5/21/2012
-
Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), Union City, Calif. Business: Neurology, Autoimmune Date announced: 5/16/12 Questcor said its board authorized the repurchase of an additional 5 million of the company's …
Published on 5/21/2012